News Conference News ACC 2022 Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM Yael L. Maxwell April 02, 2022
News Daily News A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients Caitlin E. Cox March 31, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News ‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible Michael O'Riordan March 21, 2022
News Daily News Guideline-Directed Therapies Underused in Frail HF Patients L.A. McKeown March 11, 2022
News Daily News Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy Todd Neale March 07, 2022
News Conference News ISC 2022 Stroke Thrombectomy Also Benefits Kids, Observational Study Shows Todd Neale February 16, 2022
News Conference News STS 2022 Higher Mortality After MV Surgery in Poorer Communities: STS Database Michael O'Riordan February 02, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Studies Zero in on Delayed Conduction Problems After TAVI Todd Neale December 21, 2021
News Daily News British Medical Groups Express Concern About Inclisiran Rollout Michael O'Riordan December 14, 2021
News Daily News New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT Michael O'Riordan December 09, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021